Canaccord lowered the firm’s price target on Curaleaf (CURLF) to C$5 from C$6 and keeps a Buy rating on the shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CURLF:
- Curaleaf Intl secures regulatory approval for handheld liquid inhalation device
- Curaleaf Holdings’ Mixed Q1: Growth Amid Challenges
- Curaleaf Holdings Reports Q1 2025 Financial Results
- Curaleaf Holdings Reports Q1 2025 Results with Strong International Growth
- Curaleaf reports Q1 adjusted cont ops EPS (7c) vs. (6c) last year
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue